Abstract：Objective: To analyze the expression levels of SCL/TALl interrupting locus (STIL) and proline-rich protein 11 (PRR11) in cervical cancer tissues and their correlation with lymph node metastasis. Methods: A total of 143 patients with cervical cancer admitted to the hospital were enrolled as the research subjects between January 2020 and January 2022. During surgery, cervical cancer tissues and adjacent normal para-carcinoma tissues were collected. The levels of STIL and PRR11 in cancer tissues and para-carcinoma tissues were detected by Western Blot. The mRNA levels of STIL and PRR11 were detected by quantitative real-time polymerase chain reaction (qRT-PCR). The levels of STIL and PRR11 in patients with different FIGO staging, and between patients with or without lymph node metastasis were compared. The diagnostic value of STIL and PRR11 for lymph node metastasis was analyzed by receiver operating characteristic (ROC) curves, which were represented by the area under the curve (AUC). The correlation between STIL and PRR11 was analyzed by the Pearson method. Results: The levels of STIL and PRR11, and relative expression levels of their genes in cervical cancer tissues were significantly higher than those in para-carcinoma tissues (P<0.05). The higher the FIGO staging, the higher the levels of STIL and PRR11 (P<0.05). The levels of STIL and PRR11 in patients with lymph node metastasis were significantly higher than those without metastasis (P<0.05). AUC values of STIL and PRR11 in the diagnosis of lymph node metastasis were 0.733 and 0.729, respectively (P<0.05). Pearson correlation analysis showed that there was a significant correlation between STIL and PRR11 in cancer tissues (P<0.05). Conclusion: The expressions of STIL and PRR11 are up-regulated in cervical cancer tissues. And their increase indicates the increased risk of lymph node metastasis. STIL and PRR11 can assess lymph node metastasis in cervical cancer.
甘露, 刘伟, 潘琴, 居文惠. STIL和PRR11在宫颈癌组织的表达水平及其与淋巴结转移的相关性[J]. 河北医学, 2022, 28(9): 1438-1441.
GAN Lu, et al. The Expression Levels of STIL and PRR11 in Cervical Cancer Tissues and Their Correlation with Lymph Node Tissue Metastasis. HeBei Med, 2022, 28(9): 1438-1441.
[1] Gao Y,Wang H,Zhong A,et al.prognosis of cyclina and CDK2 in patients with advanced cervical cancer after chemotherapy[J].Cell Mol Biol,2020,66(3):85-91. [2] Ji S F,Wen S L,Sun Y,et al.The biological function and clinical significance of STIL in osteosarcoma[J].Cancer Cell Int,2021,21(1):218-236. [3] Chen J,Yang H M,Zhou H C,et al.PRR11 and SKA2 promote the proliferation,migration and invasion of esophageal carcinoma cells[J].Oncol Lett,2020,20(1):639-646. [4] Wei Z L,Wang R,Yin X,et al.PRR11 induces filopodia formation and promotes cell motility via recruiting ARP2/3 complex in non-small cell lung cancer cells[J].Genes Dis,2021,9(1):230-244. [5] 李和禹.STIL在结肠癌组织中的表达及临床意义[D].内蒙古医科大学,2020. [6] 中华人民共和国国家卫生健康委员会.宫颈癌诊疗规范(2018年版)[J].肿瘤综合治疗电子杂志,2020,6(3):33-43. [7] 刘佳琪,李朋飞,纪妹,等.基于中国子宫颈癌临床诊疗大数据的子宫颈癌诊疗规范化调查分析[J].中国实用妇科与产科杂志,2021,37(1):82-86. [8] Johnson C A,James D,Marzan A,et al.Cervical cancer:an overview of pathophysiology and management[J].Semin Oncol Nurs,2019,35(2):166-174. [9] Ito H,Tsunoda T,Riku M,et al.Indispensable role of STIL in the regulation of cancer cell motility through the lamellipodial accumulation of ARHGEF7-PAK1 complex[J].Oncogene,2020,39(9):1931-1943. [10] 李垚.STIL在宫颈癌组织中的表达及意义[D].江西:南昌大学,2019. [11] Hau S O,Wahlin S,Cervin S,et al.PRR11 unveiled as a top candidate biomarker within the RBM3-regulated transcriptome in pancreatic cancer[J].Pathol Clin Res,2022,8(1):65-77. [12] Yang J,Shen Y,Wu R Q,et al.Increased trafficking of mesenteric lymph-derived gammadelta T cells into intestinal mucosa is associated with gut injury after intestinal ischemia-reperfusion in rats[J].Lymphology,2019,52(2):71-81. [13] 赵郑,逄子瑶,徐丽萍,等.PRR11和SKA2在宫颈癌组织中的表达及其与预后的关系[J].中国癌症防治杂志,2020,12(2):206-211.
2022, Vol. 28 
冀公网安备13080202000677号